PDL BioPharma, Inc. Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets
PDL BioPharma, Inc. had Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets of $2.76 million as of 2018-01-06, per its 10-Q filed 2018-11-07.
Discontinued › Notes › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation › Business Combination, Recognized Asset Acquired, Asset
us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets · last filed 2020-06-29
- 2018-01-06: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets $2.76M.
- 2018-01-05: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets $2.76M.
- 2016-07-01: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets $244.31M.
| Period end | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets |
|---|---|
| 2018-01-06 | $2.76M 10-Q · filed 2018-11-07 |
| 2018-01-05 | $2.76M 8-K · filed 2020-06-29 |
| 2016-07-01 | $244.31M 10-Q · filed 2017-11-13 |